Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis 2015-2019 and Forecast 2020-2025
Table of Content
1 Industrial Chain Overview
- 1.1 Oral Solid Dosage Pharmaceutical Formulation Industry
- 1.1.1 Overview
Figure Oral Solid Dosage Pharmaceutical Formulation Picture List
- 1.1.2 Characteristics of Oral Solid Dosage Pharmaceutical Formulation
- 1.2.1 Major Materials
- 1.2.2 Manufacturing Overview
- 1.3.1 By Form
- 1.3.2 Capsules
- 1.3.3 Powders
- 1.3.4 Tablets
- 1.3.5 By Drug Release Mechanism
- 1.3.6 Immediate Release
- 1.3.7 Extended Release
- 1.4.1 Demand in Hospitals
- 1.4.2 Demand in Clinics
- 1.4.3 Demand in Other
- 1.5.1 Global Market Size and Forecast, 2016-2026
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
- 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
- 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
- 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
- 2.1 Global Production & Consumption
- 2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
- 2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
- 2.2 Geographic Production & Consumption
- 2.2.1 Production
- 2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.1.2 North America
- 2.2.1 Production
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.2 Consumption
- 2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
- 2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
- 3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
- 3.2 Manufacturers List
- 3.2.1 AstraZeneca Plc. Overview
Table AstraZeneca Plc. Overview List
- 3.2.1.1 Product Specifications
- 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of AstraZeneca Plc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.1.3 Recent Developments
- 3.2.1.4 Future Strategic Planning
Table Bristol-Myers Squibb Company Overview List
- 3.2.2.1 Product Specifications
- 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.2.3 Recent Developments
- 3.2.2.4 Future Strategic Planning
Table Eli Lilly and Company Overview List
- 3.2.3.1 Product Specifications
- 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Eli Lilly and Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.3.3 Recent Developments
- 3.2.3.4 Future Strategic Planning
Table Gilead Sciences Overview List
- 3.2.4.1 Product Specifications
- 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Gilead Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.4.3 Recent Developments
- 3.2.4.4 Future Strategic Planning
Table Merck & Co. Inc. Overview List
- 3.2.5.1 Product Specifications
- 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Merck & Co. Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.5.3 Recent Developments
- 3.2.5.4 Future Strategic Planning
Table Novartis AG Overview List
- 3.2.6.1 Product Specifications
- 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.6.3 Recent Developments
- 3.2.6.4 Future Strategic Planning
Table Pfizer Inc. Overview List
- 3.2.7.1 Product Specifications
- 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Pfizer Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.7.3 Recent Developments
- 3.2.7.4 Future Strategic Planning
Table AbbVie Inc. Overview List
- 3.2.8.1 Product Specifications
- 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of AbbVie Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.8.3 Recent Developments
- 3.2.8.4 Future Strategic Planning
Table Boehringer Ingelheim GmbH Overview List
- 3.2.9.1 Product Specifications
- 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Boehringer Ingelheim GmbH (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.9.3 Recent Developments
- 3.2.9.4 Future Strategic Planning
Table Hoffman-La-Roche Ltd. Overview List
- 3.2.10.1 Product Specifications
- 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Hoffman-La-Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.10.3 Recent Developments
- 3.2.10.4 Future Strategic Planning
Table Johnson & Johnson Overview List
- 3.2.11.1 Product Specifications
- 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.11.3 Recent Developments
- 3.2.11.4 Future Strategic Planning
Table Biogen Inc. Overview List
- 3.2.12.1 Product Specifications
- 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Biogen Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.12.3 Recent Developments
- 3.2.12.4 Future Strategic Planning
Table Bayer AG Overview List
- 3.2.13.1 Product Specifications
- 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.13.3 Recent Developments
- 3.2.13.4 Future Strategic Planning
Table Teva Pharmaceticals Overview List
- 3.2.14.1 Product Specifications
- 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Teva Pharmaceticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.14.3 Recent Developments
- 3.2.14.4 Future Strategic Planning
Table Amgen Inc. Overview List
- 3.2.15.1 Product Specifications
- 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Amgen Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.15.3 Recent Developments
- 3.2.15.4 Future Strategic Planning
Table Takeda Pharmaceutical Company Ltd. Overview List
- 3.2.16.1 Product Specifications
- 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Takeda Pharmaceutical Company Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.16.3 Recent Developments
- 3.2.16.4 Future Strategic Planning
Table Otsuka Pharmaceutical Co., Ltd. Overview List
- 3.2.17.1 Product Specifications
- 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Otsuka Pharmaceutical Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.17.3 Recent Developments
- 3.2.17.4 Future Strategic Planning
Table Shire Plc. Overview List
- 3.2.18.1 Product Specifications
- 3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Shire Plc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.18.3 Recent Developments
- 3.2.18.4 Future Strategic Planning
Table Celgene Corporation Overview List
- 3.2.19.1 Product Specifications
- 3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.19.3 Recent Developments
- 3.2.19.4 Future Strategic Planning
Table Astellas Pharma Inc. Overview List
- 3.2.20.1 Product Specifications
- 3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Astellas Pharma Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
- 3.2.20.3 Recent Developments
- 3.2.20.4 Future Strategic Planning
4 Market Competition Pattern
- 4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
- 4.2 Company Market Share
- 4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
- 4.2.2 Market Concentration Analysis
- 4.3.1 Merger & Acquisition
- 4.3.2 New Product Launch
5 Product Type Segment
- 5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
- 5.2 Segment Subdivision by Product Type
- 5.2.1 Market in By Form
- 5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in By Form, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in By Form, 2016-2020, in Volume
- 5.2.1.2 Situation & Development
- 5.2.1 Market in By Form
- 5.2.2 Market in Capsules
- 5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Capsules, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Capsules, 2016-2020, in Volume
- 5.2.2.2 Situation & Development
- 5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Powders, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Powders, 2016-2020, in Volume
- 5.2.3.2 Situation & Development
- 5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Tablets, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Tablets, 2016-2020, in Volume
- 5.2.4.2 Situation & Development
- 5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in By Drug Release Mechanism, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in By Drug Release Mechanism, 2016-2020, in Volume
- 5.2.5.2 Situation & Development
- 5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Immediate Release, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Immediate Release, 2016-2020, in Volume
- 5.2.6.2 Situation & Development
- 5.2.7.1 Market Size
Figure Global Market Amount and Growth Rate in Extended Release, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Extended Release, 2016-2020, in Volume
- 5.2.7.2 Situation & Development
6 End-Use Segment
- 6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
- 6.2 Segment Subdivision
- 6.2.1 Market in Hospitals
- 6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Hospitals, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Hospitals, 2016-2020, in Volume
- 6.2.1.2 Situation & Development
- 6.2.1 Market in Hospitals
- 6.2.2 Market in Clinics
- 6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Clinics, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Clinics, 2016-2020, in Volume
- 6.2.2.2 Situation & Development
- 6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Other, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Other, 2016-2020, in Volume
- 6.2.3.2 Situation & Development
7 Market Forecast & Trend
- 7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
- 7.2 Consumption Forecast
- 7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
- 7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
- 7.3 Investment Trend
- 7.4 Consumption Trend
8 Price & Channel
- 8.1 Price and Cost
- 8.1.1 Price
- 8.1.2 Cost
Figure Cost Component Ratio
- 8.2 Channel Segment
9 Market Drivers & Investment Environment
- 9.1 Market Drivers
- 9.2 Investment Environment
- 9.3 Impact of Coronavirus on the Oral Solid Dosage Pharmaceutical Formulation Industry
- 9.3.1 Impact on Industry Upstream
- 9.3.2 Impact on Industry Downstream
- 9.3.3 Impact on Industry Channels
- 9.3.4 Impact on Industry Competition
- 9.3.5 Impact on Industry Employment
10 Research Conclusion
List of Tables
List of Table
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table AstraZeneca Plc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of AstraZeneca Plc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Eli Lilly and Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Gilead Sciences Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Gilead Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Merck & Co. Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Merck & Co. Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Pfizer Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table AbbVie Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of AbbVie Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Boehringer Ingelheim GmbH (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Hoffman-La-Roche Ltd. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Hoffman-La-Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Biogen Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Biogen Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Teva Pharmaceticals Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Teva Pharmaceticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Amgen Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Amgen Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Ltd. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Takeda Pharmaceutical Company Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Otsuka Pharmaceutical Co., Ltd. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Otsuka Pharmaceutical Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Shire Plc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Shire Plc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Astellas Pharma Inc. Overview List
Table Oral Solid Dosage Pharmaceutical Formulation Business Operation of Astellas Pharma Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Se
Summary
According to 99Strategy, the Global Oral Solid Dosage Pharmaceutical Formulation Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Oral Solid Dosage Pharmaceutical Formulation market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca Plc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Gilead Sciences
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
AbbVie Inc.
Boehringer Ingelheim GmbH
Hoffman-La-Roche Ltd.
Johnson & Johnson
Biogen Inc.
Bayer AG
Teva Pharmaceticals
Amgen Inc.
Takeda Pharmaceutical Company Ltd.
Otsuka Pharmaceutical Co., Ltd.
Shire Plc.
Celgene Corporation
Astellas Pharma Inc.
Key Product Type
By Form
Capsules
Powders
Tablets
By Drug Release Mechanism
Immediate Release
Extended Release
Market by Application
Hospitals
Clinics
Other
Main Aspects covered in the Report
Overview of the Oral Solid Dosage Pharmaceutical Formulation market including production, consumption, status & forecast and market growth
2016-2020 historical data and 2021-2026 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Impact of Coronavirus on the Industry